Program
mRNA Seasonal Flu vaccine
In GlaxoSmithKline’s pipeline, mRNA vaccine
. Its studies are mostly in Influenza, Human, led by GlaxoSmithKline.
Furthest: phase 3, since Sep 1, 20262 company-led studies, 2 open or runningNext primary completion: Jul 9, 2027 (phase 3)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| GlaxoSmithKline | 22 open or running | phase 3since Sep 1, 2026 | Sep 1, 2026 | Jul 9, 2027phase 3 · NCT07851246 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Sep 1, 2026First studies: 2 phase 3 studies in Influenza, HumanFirst studyNCT07805707, NCT07851246
Ahead
- Jul 9, 2027Primary completion: phase 3 study in Influenza, HumanNCT07851246
- Jun 9, 2028Primary completion: phase 3 study in Influenza, HumanNCT07805707
TargetBeta
A vaccine: it acts on a pathogen, not a human gene.
“mRNA vaccine”the company's pipeline, read by Claude · source
“mRNA Seasonal Flu vaccine”name, by rule
Studies
All 2 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07851246Influenza, Human · United States | 3 | Recruiting | Jul 9, 2027 | 3,000 |
| NCT07805707Influenza, Human · United States | 3 | Recruiting | Jun 9, 2028 | 54,000 |
How it is read
Names in the registry
- “mRNA Seasonal Flu vaccine”, 2 entries
Conditions, from the studies’ own filings
- Influenza, Human, 2 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.